Wealth Enhancement Advisory Services
BIO icon

Wealth Enhancement Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
926
+23
+3% +$6.52K ﹤0.01% 3283
2026
Q1 		$253K Sell
903
-265
-23% -$76.3K ﹤0.01% 2940
2025
Q4 		$380K Buy
1,168
+95
+9% +$29.6K ﹤0.01% 2708
2025
Q3 		$318K Buy
1,073
+128
+14% +$34.8K ﹤0.01% 2737
2025
Q2 		$238K Buy
+945
New +$223K ﹤0.01% 2845
2025
Q1 		– Sell
-895
Closed -$294K – 3000
2024
Q4 		$294K Buy
895
+38
+4% +$12.9K ﹤0.01% 2398
2024
Q3 		$287K Sell
857
-90
-10% -$28.6K ﹤0.01% 2210
2024
Q2 		$259K Buy
947
+82
+9% +$23.9K ﹤0.01% 2085
2024
Q1 		$299K Buy
865
+72
+9% +$23.7K ﹤0.01% 1921
2023
Q4 		$256K Sell
793
-321
-29% -$101K ﹤0.01% 1929
2023
Q3 		$399K Buy
+1,114
New +$430K ﹤0.01% 1568
2018
Q1 		– Sell
-1,324
Closed -$329K – 144
2017
Q4 		$329K Buy
+1,324
New +$321K 0.02% 135
2016
Q2 		– Sell
-8,161
Closed -$1.11M – 115
2016
Q1 		$1.11M Buy
8,161
+1,319
+19% +$173K 0.23% 92
2015
Q4 		$949K Buy
+6,842
New +$948K 0.24% 92

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wealth Enhancement Advisory Services's BIO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Bio-Rad Laboratories Class A (BIO) stake by 2.5% in Q2 2026, buying an estimated $6.52K and bringing the position to 926 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

Wealth Enhancement Advisory Services first reported a position in BIO in Q4 2015 and has held it in 14 quarters since. The position peaked at $1.11M in Q1 2016. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Wealth Enhancement Advisory Services held 926 shares of Bio-Rad Laboratories Class A worth $274K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 23 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $6.52K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3283 holding.
  • Wealth Enhancement Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q4 2015 and has held it in 14 quarters since.
  • Wealth Enhancement Advisory Services's Bio-Rad Laboratories Class A position peaked at $1.11M in Q1 2016.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.